93 related articles for article (PubMed ID: 6330589)
21. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
22. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
Komori T; Yamamoto K
Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629
[TBL] [Abstract][Full Text] [Related]
23. [Peptides--inhibitors of carboxycathepsin (peptidyl-dipeptidase A) and their role in clinical medicine].
Orekhovich VN; Eliseeva IuE; Pavlikhina LV; Krit NA; Filatova MP
Vopr Med Khim; 1984; 30(3):51-6. PubMed ID: 6206649
[TBL] [Abstract][Full Text] [Related]
24. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine.
Saruta T; Suzuki H; Okuno T; Kondo K
Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110
[TBL] [Abstract][Full Text] [Related]
25. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
26. [Antinephritic effect of SA-446, an angiotensin I converting enzyme inhibitor, on crescentic-type anti-GBM nephritis in rats].
Suzuki Y; Ito M; Yamada H; Saitho N; Tsukushi Y
Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1485-93. PubMed ID: 3007819
[No Abstract] [Full Text] [Related]
27. Resolution of captopril-induced rash after substitution of enalapril.
Rotmensch HH; Vlasses PH; Ferguson RK
Pharmacotherapy; 1983; 3(2 Pt 1):131-3. PubMed ID: 6304662
[No Abstract] [Full Text] [Related]
28. Captopril and MK-421: stability on storage, distribution to the central nervous system, and onset of activity.
Cohen ML; Kurz K
Fed Proc; 1983 Feb; 42(2):171-5. PubMed ID: 6295820
[No Abstract] [Full Text] [Related]
29. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibitors: past, present, and bright future.
Edwards CR; Padfield PL
Lancet; 1985 Jan; 1(8419):30-4. PubMed ID: 2856956
[No Abstract] [Full Text] [Related]
31. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
Cohen ML; Kurz KD; Schenck KW
J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
[No Abstract] [Full Text] [Related]
32. Toxicity study of the angiotensin converting enzyme inhibitor rentiapril in rats.
Takase K; Ikuse T; Aono H; Okahara A
Arzneimittelforschung; 1995 Jan; 45(1):15-8. PubMed ID: 7893262
[TBL] [Abstract][Full Text] [Related]
33. [The effect of captopril and enalapril on the cerebral circulation of normotensive rats].
Adzhienko LM; Isaak AD
Eksp Klin Farmakol; 1999; 62(3):18-9. PubMed ID: 10439941
[TBL] [Abstract][Full Text] [Related]
34. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
[TBL] [Abstract][Full Text] [Related]
35. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats].
Suda H; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):517-23. PubMed ID: 6298082
[TBL] [Abstract][Full Text] [Related]
36. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
Nagata S; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
[TBL] [Abstract][Full Text] [Related]
37. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
Demeilliers B; Jover B; Mimran A
J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
[TBL] [Abstract][Full Text] [Related]
38. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
[TBL] [Abstract][Full Text] [Related]
39. [ACE inhibitor therapy of hemodialyzed patients].
Pató E; Radó J
Orv Hetil; 1997 Jul; 138(30):1903-7. PubMed ID: 9289689
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
